Table 4.

Delineated Lamina Cribrosa Subregions by Quadrant and Treatment

Landmark	Quadrant	Control Eyes			Glaucoma Eyes
		Image Type		P	Image Type		P
		Conventional (Mean ± SD)	EDI (Mean ± SD)		Conventional (Mean ± SD)	EDI (Mean ± SD)
ALCS	Superior	4 ± 3	7 ± 2	0.004	4 ± 3	7 ± 3	<0.0001
	Inferior	4 ± 3	6 ± 3	0.027	3 ± 3	5 ± 3	0.008
	Nasal	11 ± 4	13 ± 3	0.27	10 ± 4	11 ± 3	0.15
	Temporal	12 ± 3	13 ± 3	0.45	11 ± 5	13 ± 2	0.10
PLCS	Superior	1 ± 2	4 ± 3	<0.0001	<1	4 ± 3	<0.0001
	Inferior	1 ± 1	4 ± 3	<0.0001	1 ± 1	3 ± 3	<0.0001
	Nasal*	5 ± 6	10 ± 4	<0.0001	2 ± 3	8 ± 4	<0.0001
	Temporal*	6 ± 5	11 ± 3	<0.0001	2 ± 3	9 ± 4	<0.0001

Bold: significant difference between conventional and EDI (P < 0.005, ANOVA).

^*Interaction between treatment and Image type is significant for this landmark and quadrant (P < 0.005, ANOVA).